Yeji
NDA/BLA filedconf 0.95

exagamglogene autotemcel — NDA/BLA filed

$CRSP · CRISPR Therapeutics AG · severe sickle cell disease (SCD)
Event date
Date TBD
Sponsor runway
6+ yrs
$2.44B liquid

Evidence

“FDA Accepts Biologics License Applications for exagamglogene autotemcel (exa-cel) for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia”
Source: Press release · 2023-06-09View press release ↗

Comparable historical nda/bla fileds· last 5 years · same indication

TickerDrugDateOutcome
$CRSPexagamglogene autotemcel2023-06-08unknown

Recent insider activity· ±90 days

No insider Form 4 activity reported on $CRSP in the 90 days around this event.
← All catalysts for $CRSP